Új-Zéland - angol - Medsafe (Medicines Safety Authority)

actavis new zealand limited - docetaxel 140mg - concentrate for injection - 140 mg - active: docetaxel 140mg excipient: citric acid ethanol nitrogen polysorbate 80 povidone

Új-Zéland - angol - Medsafe (Medicines Safety Authority)

actavis new zealand limited - docetaxel 140mg - concentrate for injection - 140 mg - active: docetaxel 140mg excipient: citric acid ethanol nitrogen polysorbate 80 povidone

Jordánia - angol - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية أداتكو - adatco drug store - evolocumab 140 mg/ml - 140 mg/ml

Jordánia - angol - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية أداتكو - adatco drug store - evolocumab 140 mg/ml - 140 mg/ml

Egyesült Államok - angol - NLM (National Library of Medicine)

remedyrepack inc. - gabapentin (unii: 6cw7f3g59x) (gabapentin - unii:6cw7f3g59x) - gabapentin is indicated for: - management of postherpetic neuralgia in adults - adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy gabapentin is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs (aeds), such as gabapentin, during pregnancy. encourage women who are taking gabapentin during pregnancy to enroll in the north american antiepileptic drug (naaed) pregnancy registry by calling the toll free number 1-888-233-2334 or visiting http://www.aedpregnancyregistry.org/. risk summary there are no adequate data on the developmental risks associated with the use of gabapentin in pregnant women. in nonclinical studies in mice, rats, and rabbits, gabapentin was developmentally toxic (increased fetal skeletal an

Új-Zéland - angol - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - temozolomide 140mg;   - capsule - 140 mg - active: temozolomide 140mg   excipient: colloidal silicon dioxide gelatin lactose sodium starch glycolate stearic acid tartaric acid tekprint black sw-9008 - temaccord capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment.

Új-Zéland - angol - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - temozolomide 140mg - capsule - 140 mg - active: temozolomide 140mg excipient: colloidal silicon dioxide gelatin indigo carmine lactose sodium laurilsulfate sodium starch glycolate stearic acid tartaric acid tekprint black sw-9008 tekprint black sw-9010 titanium dioxide

Szingapúr - angol - HSA (Health Sciences Authority)

pfizer private limited - estramustine phosphate sodium eqv estramustine - capsule - 140 mg - estramustine phosphate sodium eqv estramustine 140 mg

Új-Zéland - angol - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - ibrutinib 140mg;  ;   - capsule - 140 mg - active: ibrutinib 140mg     excipient: croscarmellose sodium gelatin magnesium stearate microcrystalline cellulose opacode black s-1-17822 opacode black s-1-17823 sodium laurilsulfate titanium dioxide - imbruvica is indicated for the treatment of · patients with mcl who have received at least one prior therapy

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - selexipag, quantity: 1400 microgram - tablet, film coated - excipient ingredients: mannitol; maize starch; hyprolose; hypromellose; propylene glycol; magnesium stearate; titanium dioxide; carnauba wax; iron oxide yellow - uptravi is indicated for the treatment of:,- idiopathic pulmonary arterial hypertension;,- heritable pulmonary arterial hypertension;,- pulmonary arterial hypertension associated with connective tissue disease;,-pulmonary arterial hypertension associated with congenital heart disease with repaired shunts;,-pulmonary arterial hypertension associated with drugs and toxins;,in patients with who functional class ii, iii or iv symptoms